PET-CT Improved High-risk Prostate Cancer Staging in Trial | Oncology | JAMA | JAMA Network

PET-CT Improved High-risk Prostate Cancer Staging in Trial | Oncology | JAMA | JAMA Network: In a recent phase 3 trial, a novel imaging technique that identifies prostate-specific membrane antigen (PSMA) on tumor cells was more accurate than the scans typically used to stage high-risk prostate cancer before surgery or radiotherapy. The crossover study compared a combination of PSMA positron...